Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form
In this study an effective method was developed to assay erythromycin ethylsuccinate for an oral suspension dosage form. The chromatographic separation was achieved on an X-Terra[superscript ™] C[subscript 18] analytical column. A mixture of acetonitrile–ammonium dihydrogen phosphate buffer (0.025 m...
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Elsevier
2015
|
| Online Access: | http://hdl.handle.net/1721.1/96353 |
| _version_ | 1826209464002281472 |
|---|---|
| author | Kamarei, Fahimeh Movaghari, Farshid Ghaffari, Alireza Soltani Bozchalooi, Iman Zamani, Ali Jabbari, Ali |
| author2 | Massachusetts Institute of Technology. Department of Mechanical Engineering |
| author_facet | Massachusetts Institute of Technology. Department of Mechanical Engineering Kamarei, Fahimeh Movaghari, Farshid Ghaffari, Alireza Soltani Bozchalooi, Iman Zamani, Ali Jabbari, Ali |
| author_sort | Kamarei, Fahimeh |
| collection | MIT |
| description | In this study an effective method was developed to assay erythromycin ethylsuccinate for an oral suspension dosage form. The chromatographic separation was achieved on an X-Terra[superscript ™] C[subscript 18] analytical column. A mixture of acetonitrile–ammonium dihydrogen phosphate buffer (0.025 mol L[superscript -1]) (60:40, V/V) (pH 7.0) was used as the mobile phase, effluent flow rate monitored at 1.0 mL min[superscript −1], and UV detection at 205 nm. In forced degradation studies, the effects of acid, base, oxidation, UV light and temperature were investigated showing no interference in the peak of drug. The proposed method was validated in terms of specificity, linearity, robustness, precision and accuracy. The method was linear at concentrations ranging from 400 to 600 μg mL[superscript −1], precise (intra- and inter-day relative standard deviations <0.65), accurate (mean recovery; 99.5%). The impurities and degradation products of erythromycin ethylsuccinate were selectively determined with good resolution in both the raw material and the final suspension forms. The method could be useful for both routine analytical and quality control assays of erythromycin ethylsuccinate in commercial powder for an oral suspension dosage form and it could be a very powerful tool to investigate the chemical stability of erythromycin ethylsuccinate. |
| first_indexed | 2024-09-23T14:22:55Z |
| format | Article |
| id | mit-1721.1/96353 |
| institution | Massachusetts Institute of Technology |
| language | en_US |
| last_indexed | 2024-09-23T14:22:55Z |
| publishDate | 2015 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | mit-1721.1/963532022-10-01T20:57:25Z Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form Kamarei, Fahimeh Movaghari, Farshid Ghaffari, Alireza Soltani Bozchalooi, Iman Zamani, Ali Jabbari, Ali Massachusetts Institute of Technology. Department of Mechanical Engineering Soltani Bozchalooi, Iman In this study an effective method was developed to assay erythromycin ethylsuccinate for an oral suspension dosage form. The chromatographic separation was achieved on an X-Terra[superscript ™] C[subscript 18] analytical column. A mixture of acetonitrile–ammonium dihydrogen phosphate buffer (0.025 mol L[superscript -1]) (60:40, V/V) (pH 7.0) was used as the mobile phase, effluent flow rate monitored at 1.0 mL min[superscript −1], and UV detection at 205 nm. In forced degradation studies, the effects of acid, base, oxidation, UV light and temperature were investigated showing no interference in the peak of drug. The proposed method was validated in terms of specificity, linearity, robustness, precision and accuracy. The method was linear at concentrations ranging from 400 to 600 μg mL[superscript −1], precise (intra- and inter-day relative standard deviations <0.65), accurate (mean recovery; 99.5%). The impurities and degradation products of erythromycin ethylsuccinate were selectively determined with good resolution in both the raw material and the final suspension forms. The method could be useful for both routine analytical and quality control assays of erythromycin ethylsuccinate in commercial powder for an oral suspension dosage form and it could be a very powerful tool to investigate the chemical stability of erythromycin ethylsuccinate. Chemi Darou Industrial Company 2015-04-02T19:00:55Z 2015-04-02T19:00:55Z 2011-01 2010-12 Article http://purl.org/eprint/type/JournalArticle 18785352 http://hdl.handle.net/1721.1/96353 Kamarei, Fahimeh, Farshid Movaghari, Alireza Ghaffari, Iman Soltani Bozchalooi, Ali Zamani, and Ali Jabbari. “Development of a Stability-Indicating High Performance Liquid Chromatography Method for Assay of Erythromycin Ethylsuccinate in Powder for Oral Suspension Dosage Form.” Arabian Journal of Chemistry 7, no. 6 (December 2014): 1079–1085. en_US http://dx.doi.org/10.1016/j.arabjc.2011.01.004 Arabian Journal of Chemistry Creative Commons Attribution-NonCommercial-NoDerivatives http://creativecommons.org/licenses/by-nc-nd/3.0/ application/pdf Elsevier Elsevier |
| spellingShingle | Kamarei, Fahimeh Movaghari, Farshid Ghaffari, Alireza Soltani Bozchalooi, Iman Zamani, Ali Jabbari, Ali Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| title | Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| title_full | Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| title_fullStr | Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| title_full_unstemmed | Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| title_short | Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| title_sort | development of a stability indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage form |
| url | http://hdl.handle.net/1721.1/96353 |
| work_keys_str_mv | AT kamareifahimeh developmentofastabilityindicatinghighperformanceliquidchromatographymethodforassayoferythromycinethylsuccinateinpowderfororalsuspensiondosageform AT movagharifarshid developmentofastabilityindicatinghighperformanceliquidchromatographymethodforassayoferythromycinethylsuccinateinpowderfororalsuspensiondosageform AT ghaffarialireza developmentofastabilityindicatinghighperformanceliquidchromatographymethodforassayoferythromycinethylsuccinateinpowderfororalsuspensiondosageform AT soltanibozchalooiiman developmentofastabilityindicatinghighperformanceliquidchromatographymethodforassayoferythromycinethylsuccinateinpowderfororalsuspensiondosageform AT zamaniali developmentofastabilityindicatinghighperformanceliquidchromatographymethodforassayoferythromycinethylsuccinateinpowderfororalsuspensiondosageform AT jabbariali developmentofastabilityindicatinghighperformanceliquidchromatographymethodforassayoferythromycinethylsuccinateinpowderfororalsuspensiondosageform |